Orna Therapeutics

Orna Therapeutics develops innovative methods and drugs in the field of RNA therapeutics. The firm plans to use its products to help treat various kinds of diseases.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price
Series B16 Aug, 2022
***
***
***
Series A24 Feb, 2021
***
***
***
Seed1 Jan, 2020
***
***
***

*** - To view the data, please log into your account or create a new one.

News related to Orna Therapeutics14

Filter by
Sort by
Orna Therapeutics
Jan 10, 2025 Show on chart

Orna Therapeutics Appoints Vikas Sinha to its Board of Directors

PRNewswire/ -- Orna Therapeutics, a biotechnology company dedicated to designing and delivering a new class of circular RNA medicines and unprecedented ...

https://www.prnewswire.com/news-releases/orna-therapeutics-appoints-vikas-sinha-to-its-board-of-directors-302347479.html
Orna Therapeutics
Jan 8, 2025 Show on chart

Orna Therapeutics Establishes Strategic Collaboration with Vertex ...

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and ...

http://www.streetinsider.com/Press+Releases/Orna+Therapeutics+Establishes+Strategic+Collaboration+with+Vertex+Pharmaceuticals+to+Develop+Next+Generation+Approaches+for+Sickle+Cell+Disease+%28SCD%29+and+Transfusion-Dependent+Beta+Thalassemia+%28TDT%29/24177334.html
Orna Therapeutics
Jan 8, 2025 Show on chart

Orna Therapeutics collaborates with Vertex Pharmaceuticals to ...

Orna Therapeutics, through its wholly owned subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...

https://www.msn.com/en-us/health/other/orna-therapeutics-collaborates-with-vertex-pharmaceuticals-to-develop-approaches-for-sickle-cell-disease/ar-AA1x6URj
Orna Therapeutics
Jan 7, 2025 Show on chart

Orna Therapeutics, Vertex Pharma Enter Three-year Research ...

(RTTNews) - Orna Therapeutics, through its subsidiary ReNAgade Therapeutics, announced a three-year strategic research collaboration with Vertex ...

https://www.nasdaq.com/articles/orna-therapeutics-vertex-pharma-enter-three-year-research-collaboration-quick-facts
Orna Therapeutics
Jan 7, 2025 Show on chart

Orna Therapeutics collaborates with Vertex to develop approaches ...

Orna Therapeutics partners with Vertex Pharmaceuticals to develop gene editing therapies for SCD and TDT, with potential milestone payments totaling $1B....

https://seekingalpha.com/news/4392988-orna-therapeutics-collaborates-with-vertex-pharmaceuticals-to-develop-approaches-for-sickle-cell-disease
Show more (9)

Investors2

MerckMerck
MPM CapitalMPM Capital

Orna Therapeutics Twitter